ISCHEMIA-CKD EXTEND – Clinical Outcomes at 5 years of Follow-up

Investigator Sripal Bangalore, MD, MHA summarizes the results of the ISCHEMIA-CKD EXTEND trial, which found that an invasive strategy of adding cardiac catheterization and revascularization to guideline-directed medical therapy does not reduce the 5-year risk of death compared to a conservative strategy in patients with advanced CKD and chronic coronary disease.

Immune Gut & Brain

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *